Segment Information (Tables)

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Revenue, Gross Profit, Gross Profit Margin, Operating Income (Loss), and Depreciation and Amortization Expenses by Reportable Segment

Revenue, gross profit, gross profit margin, operating income (loss), and depreciation and amortization expenses by reportable segment were as follows (in thousands, except percentage data):

	Three Months Ended
	March 31,		April 1,
Revenue	2023		2022
Precision Medicine and Manufacturing	$	69,528	$	62,782
Medical Solutions		77,640		62,050
Robotics and Automation		71,958		79,384
Total	$	219,126	$	204,216

	Three Months Ended
	March 31,			April 1,
Gross Profit	2023			2022
Precision Medicine and Manufacturing	$	34,333		$	28,387
Medical Solutions		31,886			25,230
Robotics and Automation		32,815			38,150
Unallocated Corporate and Shared Services		(1,406	)		(1,491	)
Total	$	97,628		$	90,276

	Three Months Ended
	March 31,			April 1,
Gross Profit Margin	2023			2022
Precision Medicine and Manufacturing		49.4	%		45.2	%
Medical Solutions		41.1	%		40.7	%
Robotics and Automation		45.6	%		48.1	%
Total		44.6	%		44.2	%

	Three Months Ended
	March 31,			April 1,
Operating Income (Loss)	2023			2022
Precision Medicine and Manufacturing	$	16,684		$	13,435
Medical Solutions		9,841			5,042
Robotics and Automation		12,000			18,338
Unallocated Corporate and Shared Services		(12,213	)		(12,532	)
Total	$	26,312		$	24,283

	Three Months Ended
	March 31,		April 1,
Depreciation and Amortization Expenses	2023		2022
Precision Medicine and Manufacturing	$	2,596	$	2,777
Medical Solutions		3,973		4,427
Robotics and Automation		4,845		6,737
Unallocated Corporate and Shared Services		317		103
Total	$	11,731	$	14,044

Schedule of Geographic Revenue

The Company aggregates geographic revenue based on the customer locations where products are shipped to. Revenue by geography was as follows (in thousands):

	Three Months Ended
	March 31,		April 1,
	2023		2022
United States	$	103,842	$	82,715
Germany		34,862		31,778
Rest of Europe		29,365		33,373
China		17,798		26,799
Rest of Asia-Pacific		28,111		22,840
Other		5,148		6,711
Total	$	219,126	$	204,216

Revenue By End Market

The Company primarily operates in two end markets: the medical market and the advanced industrial market. Revenue by end market was approximately as follows:

	Three Months Ended
	March 31,			April 1,
	2023			2022
Medical		54	%		47	%
Advanced Industrial		46	%		53	%
Total		100	%		100	%